Tetra Bio Pharma Inc (TBPMQ)

[Buellersback]

Very nice news!:

https://www.ema.europa.eu/en/glossary/orphan-designation

Orphan designation
A status assigned to a medicine intended for use against a rare condition. The medicine must fulfil certain criteria for designation as an orphan medicine so that it can benefit from incentives such as protection from competition once on the market.

More info here:

https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview

"About 30 million people living in the European Union (EU) suffer from a rare disease. The European Medicines Agency (EMA) plays a central role in facilitating the development and authorisation of medicines for rare diseases, which are termed 'orphan medicines' in the medical world."